| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,214 | 23,599 | 22,429 | 20,148 | | Cost of Revenue | 5,080 | 5,000 | 5,312 | 6,123 | | | Gross Profit |
-
| 18,599 | 17,116 | 14,025 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,049 | 8,613 | 7,245 | 6,531 | | Non Recurring | (700) | (51) | 409 | 342 | | Others | 6,521 | 6,154 | 5,664 | 4,692 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,883 | 3,798 | 2,461 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,265 | 3,883 | 3,798 | 2,461 | | Interest Expense | 746 | 1,093 | 1,263 | 1,598 | | Income Before Tax | 519 | 2,790 | 2,535 | 863 | | Income Tax Expense | (205) | 776 | 762 | 297 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 723 | 2,015 | 1,773 | 566 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 723 | 2,015 | 1,773 | 566 | | Preferred Stock And Other Adjustments |
-
| 238 | (238) |
-
| | | Net Income Applicable To Common Shares | ($542) | $2,252 | $1,535 | $566 |
|
0.11% Nasdaq 0.00%
Income Statement
